These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33571991)

  • 1. Angiogenic Effect of Pravastatin Alone and with Sera from Healthy and Complicated Pregnancies Studied by in vitro Vasculogenesis/Angiogenesis Assay.
    Virtanen A; Huttala O; Tihtonen K; Toimela T; Heinonen T; Laivuori H; Uotila J
    J Vasc Res; 2021; 58(3):139-147. PubMed ID: 33571991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic doses of metformin do not have impact on angiogenesis in presence of sera from pre-eclamptic, IUGR and healthy pregnancies.
    Virtanen A; Huttala O; Tihtonen K; Toimela T; Heinonen T; Laivuori H; Uotila J
    Pregnancy Hypertens; 2020 Oct; 22():7-13. PubMed ID: 32682321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong inhibitory effect of pre-eclampsia serum on angiogenesis detected in vitro by human cell-based angiogenesis tests.
    Virtanen A; Toimela T; Tihtonen K; Sarkanen JR; Huttala O; Heinonen T; Uotila J
    Pregnancy Hypertens; 2016 Oct; 6(4):367-373. PubMed ID: 27939484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic capacity in pre-eclampsia and uncomplicated pregnancy estimated by assay of angiogenic proteins and an in vitro vasculogenesis/angiogenesis test.
    Virtanen A; Huttala O; Tihtonen K; Toimela T; Heinonen T; Uotila J
    Angiogenesis; 2019 Feb; 22(1):67-74. PubMed ID: 30003436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental nitric oxide formation and endothelium-dependent vasodilation underlie pravastatin effects against angiogenic imbalance, hypertension in pregnancy and intrauterine growth restriction.
    Chimini JS; Possomato-Vieira JS; da Silva MLS; Dias-Junior CA
    Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):385-393. PubMed ID: 30318719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction.
    Schlembach D; Wallner W; Sengenberger R; Stiegler E; Mörtl M; Beckmann MW; Lang U
    Ultrasound Obstet Gynecol; 2007 Apr; 29(4):407-13. PubMed ID: 17330322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.
    Crispi F; Llurba E; Domínguez C; Martín-Gallán P; Cabero L; Gratacós E
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):303-9. PubMed ID: 18058842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
    Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
    J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia.
    Sezer SD; Küçük M; Yenisey C; Yüksel H; Odabaşı AR; Türkmen MK; Çetinkaya Çakmak B; Ömürlü IK
    Gynecol Endocrinol; 2012 Aug; 28(8):628-32. PubMed ID: 22429154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension.
    Bauer AJ; Banek CT; Needham K; Gillham H; Capoccia S; Regal JF; Gilbert JS
    Hypertension; 2013 May; 61(5):1103-10. PubMed ID: 23460290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
    Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D
    Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor (pravastatin) inhibits endothelial cell proliferation dependent on G1 cell cycle arrest.
    Asakage M; Tsuno NH; Kitayama J; Kawai K; Okaji Y; Yazawa K; Kaisaki S; Takahashi K; Nagawa H
    Anticancer Drugs; 2004 Jul; 15(6):625-32. PubMed ID: 15205608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
    Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
    J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
    Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
    Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study.
    Raia-Barjat T; Prieux C; Gris JC; Chapelle C; Laporte S; Chauleur C
    J Matern Fetal Neonatal Med; 2019 Jan; 32(2):248-257. PubMed ID: 28889770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repositioning for Preeclampsia Therapeutics by In Vitro Screening: Phosphodiesterase-5 Inhibitor Vardenafil Restores Endothelial Dysfunction via Induction of Placental Growth Factor.
    Kakigano A; Tomimatsu T; Mimura K; Kanayama T; Fujita S; Minato K; Kumasawa K; Taniguchi Y; Kanagawa T; Endo M; Ishihara T; Namba T; Mizushima T; Kimura T
    Reprod Sci; 2015 Oct; 22(10):1272-80. PubMed ID: 25736325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.